Prasugrel des acetyl impurity

Prasugrel des acetyl impurity is a deacetylated derivative of the antiplatelet drug Prasugrel, characterized by the absence of the acetyl group at the piperazine nitrogen. It retains the core thienopyridine scaffold and sulfide linkage to the pyridine ring but features a free piperazine amine. This structural modification disrupts the parent compound’s prodrug activation pathway. The impurity arises during synthetic deprotection steps or hydrolytic degradation. It serves as a critical HPLC reference standard for quantifying process-related deacetylation byproducts in Prasugrel API batches.